RSI launched the Climate Change Hazards Information Portal (CCHIP).

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa and the Center for Alternatives to Animal Testing at Johns Hopkins University. The meeting will be held at the University…

RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a term of 5 years (2018 to 2022). JEMRA is an international scientific expert group that is administered jointly by the Food and Agriculture Organization of the United Nations (FAO) and…

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records have explored the impact of drugs with anticholinergic properties. The first, “Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease” view here used a HealthFacts database (Cerner Corporation, Kansas…

A second updated edition of the CSA national permafrost standard was published on May 21, 2019 and features climate and climate change information provided by Risk Sciences International. This “CSA PLUS 4011, Technical Guide: Infrastructure in permafrost: A guideline for climate change adaptation”, supersedes the previous edition published in 2010. RSI climate scientists were involved…

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing…

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF in association with systemically administered…

Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH).  The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and valuable to USC.  Dr Mattison’s academic…

Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring and responding to new microbial threats to blood safety.  The Book was edited by Hua Shan and Roger Dodd and recently published by Springer. RSI’s Anne Wiles, is lead author for…

Engineers Canada is a partner with the German development agency Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) in the execution of their Enhanced Climate Services for Infrastructure Investment Project. RSI’s Dr. Neil Comer provided climate and climate change expertise supporting the planned construction of a major infrastructure development sited in the Mekong Delta of Vietnam.…